KZR insider buying & filings

KZRKezar Life Sciences, Inc.

—

2 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Jul 3 · scanned 14m ago

No price data yet — the yfinance scanner hasn't produced bars for KZR.

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Short % float

Pro

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Jul 3SELLSchiller Mark C.Chief Operating Officerdirect561 @ $4.28$2.4K

Jul 3SELLChiang Pichi LuoSVP, Corporate Controllerdirect264 @ $4.28$1.1K

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice